Hepatic Cytochrome P450 2B6 Polymorphisms, Nevirapine Plasma Concentrations, and clinical Outcomes of Nevirapine-based Antiretroviral Therapy in HIV-1-infected Kenyan Women

Funding: University of Washington Royalty Research Fund Proposal A61975
PI: S. McClelland
Time Period: 3/2011 – 3/2013

Hepatic Cytochrome P450 2B6 Polymorphisms, Nevirapine Plasma Concentrations, and Clinical Outcomes of Nevirapine-Based Antiretroviral Therapy in HIV-1-Infected Kenyan Women.

Comments are closed.